Eoin Brennan

Dr. Eoin Brennan is an Assistant Professor at the School of Medicine, University College Dublin, Ireland. Eoin graduated from University College Cork in 2004 with an honours degree in Genetics and in 2008 completed his PhD at Queen's University Belfast, studying the genetic and epigenetic mechanisms of diabetic kidney disease.
In 2009, Eoin moved to the UCD Diabetes Complications Research Centre, University College Dublin, Ireland to study endogenous and synthetic pro-resolving lipids (lipoxins) as novel therapeutics targeting microvascular complications of diabetes.
In 2014, Eoin continued his research at the Baker IDI Heart and Diabetes Institute, Melbourne, Australia. During this time he investigated endogenous lipids and non-coding RNA therapeutics in complications of Diabetes, with a specific focus on targeting vascular lesions in aortas and kidneys.
In 2019, Eoin was appointed an Ad Astra Assistant Professor, School of Medicine, UCD. His translationally-focused research group is investigating novel pro-resolving lipid treatment strategies for arresting the progression of vascular complications of diabetes. His multidisciplinary research programme utilises cell-based, organoid and murine models in collaboration with local clinical sites. He is also a lead investigator in the GENIE (Genetics of Nephropathy, an International Effort) Consortium, an international consortium investigating genetic and epigenetic mechanisms underpinning diabetic kidney disease